Multi-year, 1143-patient genetic study identified unique types of multiple myeloma
On Aug. 19, 2024, an international team of scientists led by researchers from the Translational Genomics Research Institute (TGen) announced…
On Aug. 19, 2024, an international team of scientists led by researchers from the Translational Genomics Research Institute (TGen) announced…
ON Aug. 16, 2024, the European Centre for Disease Prevention and Control (ECDC) reported that it is highly…
On Aug. 15, 2024, the Oakland County Health Division in Pontiac, Michigan urged residents to protect themselves from mosquito…
On Aug. 15, 2024, a study published in the journal Cancer projected an alarming increase in cancer cases and deaths…
On Aug. 14, 2024, The World Health Organization declared that the upsurge of mpox in the Democratic Republic…
on Aug. 14, 2024, research led by scientists at the Ineos Oxford Institute for antimicrobial research at Oxford…
On Aug. 7, 2024, Amneal Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved CREXONT…
On Aug. 6, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved vorasidenib (Voranigo, Servier…
On Aug. 5, 2024, North Carolina State University researchers revealed that an examination of the genetic material found…
On Aug. 2, 2024, the U.S. Food and Drug Administration approved Adaptimmune’s Tecelra (afamitresgene autoleucel), a gene therapy…
On Jul. 31, 2024, the Lancet Standing Commission released its 2024 Dementia prevention, intervention, and care report that…
On Jul. 31, 2024, a large study led by researchers at the American Cancer Society (ACS) suggested incidence…
On Jul. 30, 2024, a head-to-head comparison of six commercially available blood tests for Alzheimer’s disease led by…
On Jul. 29, 2024, a team led by the Barbara Ann Karmanos Cancer Institute and the Wayne State…
On Jul. 26, 2024, the U.S. Food and Drug Administration (FDA) approved the Guardant Health’s Shield, a test…
On Jul. 26. 2024, Boar’s Head, a Jarratt, Va., establishment, announced it was recalling all liverwurst product produced…
On Jul. 25, 2024, Pfizer announced that the European Commission (EC) has granted conditional marketing authorization for DURVEQTIX®…
On Jul. 25, 2024, doctors from the Texas Heart Institute (THI), BiVACOR®, Baylor St. Luke’s Medical Center and…
On Jul. 22, 2024, scientists at ADA Forsyth Institute (AFI) announced they had identified a critical factor that…
In Jul. 10, 2024, Eisai and Biogen announced that the Department of Health in Hong Kong has approved…
On Jul. 9, 2024, officials at the Pueblo Department of Public Health and Environment (PDPHE), in collaboration with…
On Jul. 2, 2024, a study was released that showed evidence that commercial tattoo and PMU inks are…
On Jul. 2, 2024, Emergent BioSolutions announced it had received more than $250 millionin contract modifications from the…
On Jul. 2, 2024, the World Health Organization (WHO) recommended a comprehensive set of tobacco cessation interventions, including…
On Jun. 28, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Jun. 26. 2024, the World Health Organization reported that new data show that nearly one third (31%)…
On Jun. 20, 2024, the U.S. Food and Drug Administration expanded the approval of Sarepta Therapeutics’ Elevidys (delandistrogene…
On Jul. 16, 2024, Colorado Parks and Wildlife officials announced the first finding of ‘rustrela virus’ in a…
On Jun. 12, 2024, scientists at Weill Cornell Medicine in New York City reported that just a few…
On Jun. 6, 2024, the National Institutes of Health (NIH) announced it was investing approximately $30 million in…